Catalyst Wire Dossier Catalyst Wire Dossier

Nicotinamide adenine dinucleotide (NAD) supplement

nicotinamide adenine dinucleotide
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nicotinamide adenine dinucleotide (NAD) supplement, covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: Clinical Trial Update: NAD Supplementation and Vascular Health in PAD [Phase 1, Phase 2]

See pricing